Who invested in Saros Therapeutics?
Saros Therapeutics's investors include National Cancer Institute (NCI).

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$2.0Mraised across 1 round since 2023, from 1 source
From Saros Therapeutics's own website: 1 on the team.
Saros Therapeutics's investors include National Cancer Institute (NCI).
Saros Therapeutics has raised $2.0M across 1 round since 2023.
Saros Therapeutics's most recent round was a Grant of $2.0M in Sept 2023.
Its most recent round, $2.0M in Sept 2023, is also its largest on record.
Saros Therapeutics's first round on record, in Sept 2023, was backed by National Cancer Institute (NCI).
Saros Therapeutics's latest named round is a Grant, in Sept 2023.
Saros Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.